James Edgemond Sells 21,000 Shares of United Therapeutics (NASDAQ:UTHR) Stock

United Therapeutics Corporation (NASDAQ:UTHR - Get Free Report) CFO James Edgemond sold 21,000 shares of the business's stock in a transaction on Monday, December 1st. The shares were sold at an average price of $479.99, for a total value of $10,079,790.00. Following the completion of the sale, the chief financial officer owned 8,142 shares in the company, valued at approximately $3,908,078.58. The trade was a 72.06% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.